Related Experiment Video
Updated: Aug 4, 2025

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection
Rohan Merani1,2,3, Mark W Johnson4, Colin A McCannel5
1Concord Repatriation General Hospital, Sydney, NSW, Australia.
Abstract:
Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management

